←Back to Expert Scholars
Translational Medicine / 转化医学Progesterone Receptor and Translation, Breast Cancer
Hope Rugo
MD
🏢UCSF Helen Diller Family Comprehensive Cancer Center🌐USA
Professor, Director Breast Oncology Clinical Trials
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Hope Rugo directs breast oncology clinical trials at UCSF and has led multiple landmark HR positive breast cancer trials, including studies of CDK4/6 inhibitors and antibody drug conjugates. Her work integrates ER and PR expression with treatment selection and resistance monitoring.
Share:
🧪Research Fields 研究领域
HR positive breast cancer trials
CDK4/6 inhibitors
ADCs breast
metastatic breast cancer
clinical research
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Hope Rugo 的研究动态
Follow Hope Rugo's research updates
留下邮箱，当我们发布与 Hope Rugo（UCSF Helen Diller Family Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment